DWA
BMY icon

Dorsey Wright & Associates’s Bristol-Myers Squibb BMY Stock Holding History

Dorsey Wright & Associates’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-27,876
Closed -$1.64M – 312
2020
Q2 		$1.64M Sell
27,876
-2,413
-8% -$144K 0.33% 90
2020
Q1 		$1.69M Buy
+30,289
New +$1.85M 0.64% 75

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Dorsey Wright & Associates's BMY Position: Q3 2020 in Review

Dorsey Wright & Associates sold out of Bristol-Myers Squibb (BMY) in Q3 2020, closing a stake of 27,876 shares — an estimated $1.64M sold.

Dorsey Wright & Associates first reported a position in BMY in Q1 2020 and held it in 2 quarters. The position peaked at $1.69M in Q1 2020. 2,214 funds tracked by Wall St. Rank hold BMY as of Q3 2020.

  • Dorsey Wright & Associates reported no remaining Bristol-Myers Squibb position as of Q3 2020 after selling out during the quarter.
  • Dorsey Wright & Associates sold 27,876 Bristol-Myers Squibb shares in Q3 2020, an estimated $1.64M.
  • Dorsey Wright & Associates first reported a position in Bristol-Myers Squibb in Q1 2020 and held it in 2 quarters.
  • Dorsey Wright & Associates's Bristol-Myers Squibb position peaked at $1.69M in Q1 2020.
  • 2,214 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2020.

Based on Dorsey Wright & Associates's 13F filing for Q3 2020, filed 28 Oct 2020.